
The FDA grants accelerated approval to neladalkib for pretreated ALK-positive lung cancer, showing how next-gen kinase inhibitors tackle drug resistance
The 2025 theme is "Microbial Resilience: Today’s Response, Tomorrow’s Plan."
Dates: October 27–29, 2025
Location: Washington, DC
Description: The call for abstracts is now open, and prospective attendees are being encouraged to submit their abstracts to help shape the future of the industry.
Registration: Check back for updates.






